Friday, 16 October 2026European Markets

MOWI And LOTUS BAKERIES Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(VIANEWS) - MOWI (MOWI.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Consumer Defensive sector.

Financial Asset Price Forward Dividend Yield Return on Equity
MOWI (MOWI.OL) kr182.15 3.83% 23.04%
LOTUS BAKERIES (LOTB.BR) €6160.00 0.65% 18.92%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. MOWI (MOWI.OL)

3.83% Forward Dividend Yield and 23.04% Return On Equity

Mowi ASA, a seafood company, produces and supplies farmed salmon products worldwide. It operates through three segments: Feed, Farming, and Sales and Marketing. The company is involved in the salmon feed production, salmon farming and primary processing, and seafood secondary processing activities. It offers whole gutted fish, including Label Rouge and organic salmon; and white fish and other seafood products, as well as fillets, steaks, cutlets, portions, loins, kebabs, and steak combos. The company also provides value added products, such as breaded, pre-fried, dusted, marinated, grilled, battered, topped, filled with sauce, delicatessen, fresh fish ready meal, and smoked fish products. It offers its products under the Mowi, Mowi Salmon, Donegal Silver, Admiral's, Pieters, Laschinger, Kritsen, Ducktrap River, Harbour Salmon Co., Rebel Fish, Supreme Salmon, Olav's, Northern Harvest, and Mowi Nutrition brand names. The company was formerly known as Marine Harvest ASA and changed its name to Mowi ASA in December 2018. Mowi ASA was founded in 1964 and is headquartered in Bergen, Norway.

Earnings Per Share

As for profitability, MOWI has a trailing twelve months EPS of kr16.84.

PE Ratio

MOWI has a trailing twelve months price to earnings ratio of 10.82. Meaning, the purchaser of the share is investing kr10.82 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.04%.

Yearly Top and Bottom Value

MOWI's stock is valued at kr182.15 at 22:30 EST, way under its 52-week high of kr267.20 and way higher than its 52-week low of kr130.15.

Sales Growth

MOWI's sales growth is 7.7% for the ongoing quarter and 5.9% for the next.

Growth Estimates Quarters

The company's growth estimates for the present quarter is 13.8% and a drop 2.8% for the next.

More news about MOWI.

2. LOTUS BAKERIES (LOTB.BR)

0.65% Forward Dividend Yield and 18.92% Return On Equity

Lotus Bakeries NV provides various snack products in Belgium and internationally. The company offers biscuits and cakes, including caramelized cookies, gingerbreads, cake specialties, waffles, and pepparkakor biscuits. It also provides energy bars, protein flapjacks, protein nut bars, healthy snacks, butter specialties, ice creams, and caramelized cookies spreads. The company sells its products under the Lotus Biscoff, Nakd, Trek, BEAR, Kiddylicious, Lotus, Dinosaurus, Peijnenburg, Snelle Jelle, Annas, Lotus Suzy, and Urban Fruit brands. The company was founded in 1932 and is headquartered in Lembeke, Belgium. Lotus Bakeries NV is a subsidiary of Stichting Administratiekantoor van Aandelen Lotus Bakeries.

Earnings Per Share

As for profitability, LOTUS BAKERIES has a trailing twelve months EPS of €101.82.

PE Ratio

LOTUS BAKERIES has a trailing twelve months price to earnings ratio of 60.5. Meaning, the purchaser of the share is investing €60.5 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.92%.

Volume

Today's last reported volume for LOTUS BAKERIES is 164 which is 70.01% below its average volume of 547.

More news about LOTUS BAKERIES.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com